News

Around the World: JPEO-CBRND Gathers Global Data to Enhance Threat Detection Capabilities
April 15, 2024 — In recent years, the public has become more familiar with rapid biological diagnostic technologies for diseases due to the prevalence of at-home COVID-19 test kits and the 24-48-hour Polymerase Chain Reaction (PCR) tests completed in a laboratory. Developing effective tools like rapid COVID-19 tests takes a tremendous amount of performance data. As... MORE

The People Behind the Mission: A Q&A with the Women of JPL CBRND Enabling Biotechnologies
March 22, 2024 — March is Women’s History Month, so we caught up with some of our leading ladies from the Joint Project Lead for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnologies (JPL CBRND EB), to learn about their role within the organization and their sources of inspiration. JPL CBRND EB is one of two JPLs within JPEO-CBRND. Its... MORE

JPEO-CBRND Featured in APG's The Proof Winter 2024
March 11, 2024 — The JPEO-CBRND has two features in the Winter 2024 edition of APG's The Proof Magazine. The full magazine focused on APG South's tenant commands and history of chemical and research and engineering. Find the full winter edition of the magazine online:... MORE

Two people stand in a conference room wearing smart goggles.

AL&T Feature - Agile Acquisition for … Hardware?
March 7, 2024 — The interior of the Negatively Pressurized CONEX at the Center for Sustainment of Trauma and Readiness Skills in Omaha, Nebraska, in June 2023. The NPC was developed using methods typical of agile software development. (U.S. Air Force Photo)Read the full article about the JPM CBRN Protection's Negatively Pressurized Conex (NPC), which keeps... MORE

GUIDE Program Prepares DOD to Defend Against the Unknown
February 27, 2024 — Significant biological events can take different shapes and sizes, from disease to intentional poisons and anywhere in between. COVID-19 taught the world firsthand that we likely will not know what the next threat is, but that any biological event can cause great harm to society and the world. To meet this reality, Joint Program Executive Office... MORE

The graphic shows the various elements included in the decision tree for the GUIDE program. The slide is broken in two halves (right and left). The left upper corner shows a microbe, models of manufacturability, efficacy, safety data and pharmacodynamics. On the right side of the slide shows how the GUIDE program will help pair these things for the optimal output through the GUIDE program's capabilities.

Department of Defense Transitions Legacy Special Immunization Program to Commercial Partners
February 16, 2024 — Some professions are inherently risky—and for military personnel, first responders, and medical providers, special precautions are required to safely perform their duties. The same holds true for people who study infectious diseases with the aim of developing medical countermeasures to protect U.S. troops and the general population.Fort Detrick’s... MORE

Crystal Tyler, pharmacy technician, prepares an injection for an Operation Warp Speed patient volunteer at Brooke Army Medical Center, Fort Sam Houston, Texas, November 16, 2020. BAMC and Wilford Hall Ambulatory Surgical Center are participating in the Phase III trial to evaluate the vaccine under development by AstraZeneca as part of a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics.

CSC2 Moves Full Speed Ahead on the Software Acquisition Pathway
February 6, 2024 — Do you drive in a vehicle that has blind-spot warning indicators, adaptive cruise control or back-up cameras? Do you wear a smart watch or use a smart phone that integrates your entertainment, scheduling, location sharing, and warns you when you’ve been exposed to loud noises that could harm your hearing? If so, then you likely understand the power... MORE

A man stands next to a screen displaying maps and explains the results to three men sitting in chairs and listening.

JPEO-CBRND Awards $235.8 Million Procurement Contract to Emergent Biosolutions to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the DOD
January 19, 2024 — On January 9, 2024, the U.S. Department of Defense (DOD) awarded an indefinite delivery/indefinite quantity (ID/IQ) procurement contract to Emergent BioSolutions, Inc. to supply the U.S. Food and Drug Administration (FDA)-approved BioThrax® (Anthrax Vaccine Adsorbed), a pre-exposure prophylaxis (PrEP) for anthrax disease, for use by all branches of... MORE

American flags against a blue sky background

Joint Industry Day Event Inspires Collaboration and Trust in the Fight Against Chemical Nerve Agent Threats
January 3, 2024 — Medical countermeasures (MCMs) are the first line of defense against novel weapons of mass destruction (WMD) threats, and discussions surrounding the development of improved chemical agent MCM capabilities took center stage at the “Reactivators and Multi-Drug Autoinjector Industry Day” event held on 1-2 November in McLean, Virginia. U.S. government... MORE

A row of civilian and military stand in front of flags in a lobby

Sharpening the Tip of the Spear: USSOCOM Experiment Yields Valuable User Feedback for CBRN Defense Developers
December 10, 2023 — Delivering lifesaving capabilities into the hands of warfighters who need them is a mission that the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) doesn’t take lightly. Rapid access to cutting edge CBRN defense equipment is critical to the readiness and safety of the joint force, particularly... MORE

CBRN sensors on robot dogs are let into a door by a service member in full CBRN gear.

News Search

News Archive - Search by Year and Month

April 2024 (1)
March 2024 (3)
February 2024 (3)
January 2024 (2)
December 2023 (2)
November 2023 (2)
October 2023 (5)
September 2023 (6)
August 2023 (8)
July 2023 (2)
June 2023 (2)
May 2023 (3)
April 2023 (2)
March 2023 (1)
February 2023 (1)
January 2023 (1)
December 2022 (4)
November 2022 (1)
October 2022 (3)
September 2022 (5)
August 2022 (3)
July 2022 (3)
June 2022 (1)
May 2022 (1)
March 2022 (2)
February 2022 (2)
January 2022 (5)
December 2021 (1)
November 2021 (6)
October 2021 (2)
September 2021 (1)
July 2021 (1)
June 2021 (1)
May 2021 (8)
April 2021 (6)
March 2021 (2)
February 2021 (5)
January 2021 (4)
December 2020 (3)
November 2020 (1)
August 2020 (1)
July 2020 (3)
May 2020 (1)
April 2020 (1)
March 2020 (4)
February 2020 (1)
December 2019 (2)
November 2019 (2)
October 2019 (2)
September 2019 (2)
March 2019 (1)
January 2019 (2)
December 2018 (1)
October 2018 (1)
July 2018 (1)
April 2018 (1)
February 2018 (1)
December 2017 (1)
November 2017 (2)
September 2017 (1)
June 2017 (2)
January 2017 (3)
December 2016 (1)

JPEO-CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.

JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.